Advanced Techniques in Diagnostic Microbiology

More documents

Recommendations

Info

Vironostika HIV-1 Microelisa System Vironostika HIV-1 Plus O Microelisa System Cambridge Biotech HIV-1 Western Blot Kit EIA Serum/Plasma Donor Screen bioMerieux, Inc Durham, NC 27712 US License 1624 EIA Plasma/Serum/Dried Blood Spots Diagnostic Non-Donor Screen bioMerieux, Inc Durham, NC 27712 US License 1624 WB Serum/Plasma Donor Supplemental Calypte Biomedical Corp Berkeley, CA US License 1207 12/18/1987 6/6/2003 1/3/1991 Genetic Systems HIV-1 Western Blot WB Serum/Plasma Donor Supplemental Bio-Rad Laboratories Blood 11/13/1998 Virus Division Fluorognost HIV-1 IFA IFA Serum/Plasma Donor Supplemental Waldheim Pharmazeutika 2/5/1992 GmbH Vienna, Austria US License 1150 HIVAB HIV-1 EIA EIA Dried Blood Spot Non-Donor Screen Abbott Laboratories 4/22/1992 HIV-1 Urine EIA EIA Urine Screen Non-Donor Screen Calypte Biomedical Corp 8/6/1996 Genetic Systems rLAV EIA EIA Dried Blood Spot Non-Donor Screen Bio-Rad Laboratories Blood Virus Division 6/29/1998 Vironostika HIV-1 Microelisa System Oral Fluid Vironostika HIV-1 Microelisa System Cambridge Biotech HIV-1 Western Blot Kit EIA Dried Blood Spot Non-Donor Screen bioMerieux, Inc Durham, NC 27712 4/11/1990 EIA Oral Fluid Non-Donor Screen bioMerieux, Inc 12/23/1994 Durham, NC 27712 WB Urine Non-Donor Supplemental Calypte Biomedical Corp 5/28/1998 Genetic Systems HIV-1 Western Blot WB Dried Blood Spot Non-Donor Supplemental Bio-Rad Laboratories Blood 11/13/1998 Virus Division OraSure HIV-1 Western Blot Kit WB Oral Fluid Non-Donor Supplemental Epitope, Inc 6/3/1996 Fluorognost HIV-1 IFA IFA Dried Blood Spot Non-Donor Supplemental Waldheim Pharmazeutika GmbH 5/14/1996 OraQuick Rapid HIV-1 Antibody Test Rapid EIA Fingerstick Non-Donor Screen OraSure Technologies, Inc Bethlehem, PA 18015 11/7/2002 (continued) 337
Page 2:
Advanced Techniques in Diagnostic M
Page 6:
Yi-Wei Tang Molecular Infectious Di
Page 10:
vi Contributors Wonder Drake Depart
Page 14:
viii Contributors Jacques Schrenzel
Page 18:
Preface Clinical microbiologists ar
Page 22:
Contents Part I Techniques 1 Automa
Page 26:
Contents xv 22 Review of Molecular
Page 30:
1 Automated Blood Cultures XIANG Y.
Page 34:
Interpretation of Significance 1. A
Page 38:
1. Automated Blood Cultures 7 conta
Page 42:
1. Automated Blood Cultures 9 Crump
Page 46:
2 Urea Breath Tests for Detection o
Page 50:
2. Urea Breath Tests 13 and point o
Page 54:
2. Urea Breath Tests 15 Other detec
Page 58:
TABLE 2.1. Comparison of 13 C-urea
Page 62:
2. Urea Breath Tests 19 Bazzoli, F.
Page 66:
2. Urea Breath Tests 21 Logan, R. (
Page 70:
3 Rapid Antigen Tests SHELDON CAMPB
Page 74:
3. Rapid Antigen Tests 25 antigen i
Page 78:
3. Rapid Antigen Tests 27 either on
Page 82:
3. Rapid Antigen Tests 29 and moves
Page 86:
3. Rapid Antigen Tests 31 Applicati
Page 90:
Fungi Cryptococcus Agglutination, E
Page 94:
Adenovirus, enteric types 40,41 EIA
Page 98:
3. Rapid Antigen Tests 37 Antigen t
Page 102:
3. Rapid Antigen Tests 39 retains a
Page 106:
3. Rapid Antigen Tests 41 Wilhelmi,
Page 110:
4. Advanced Antibody Detection 43 D
Page 114:
TABLE 4.1. Types of antibody detect
Page 118:
4. Advanced Antibody Detection 47 c
Page 122:
4. Advanced Antibody Detection 49 U
Page 126:
4. Advanced Antibody Detection 51 a
Page 130:
4. Advanced Antibody Detection 53 a
Page 134:
4. Advanced Antibody Detection 55 H
Page 138:
4. Advanced Antibody Detection 57 r
Page 142:
4. Advanced Antibody Detection 59 A
Page 146:
4. Advanced Antibody Detection 61 M
Page 150:
5 Phenotypic Testing of Bacterial A
Page 154:
5. Antimicrobial Susceptibility Tes
Page 158:
Page 162:
Page 166:
Susceptibility Tests for Fastidious
Page 170:
Page 174:
Page 178:
Page 182:
References 5. Antimicrobial Suscept
Page 186:
Page 190:
Page 194:
6. Biochemical Profile-Based Microb
Page 198:
Page 202:
Page 206:
Page 210:
Page 214:
Page 218:
Page 222:
Page 226:
Page 230:
Page 234:
Page 238:
Page 242:
Page 246:
Page 250:
Page 254:
Page 258:
7 Rapid Bacterial Characterization
Page 262:
7. MALDI-TOF MS 119 photons followe
Page 266:
7. MALDI-TOF MS 121 for analysis by
Page 270:
7. MALDI-TOF MS 123 Sample wells Ca
Page 274:
7. MALDI-TOF MS 125 also given. Thi
Page 278:
7. MALDI-TOF MS 127 characteristics
Page 282:
References 7. MALDI-TOF MS 129 Ande
Page 286:
7. MALDI-TOF MS 131 Hindre, T., Did
Page 290:
7. MALDI-TOF MS 133 von Wintzingero
Page 294:
8. Probe-Based Microbial Detection
Page 298:
Page 302:
Page 306:
Page 310:
9 Pulsed-Field Gel Electrophoresis
Page 314:
9. Pulsed-Field Gel Electrophoresis
Page 318:
Page 322:
PFGE Performance Characteristics 9.
Page 326:
Page 330:
Page 334:
Page 338:
Page 342:
TABLE 10.1. Nucleic acid amplificat
Page 346:
10. In Vitro Nucleic Acid Amplifica
Page 350:
Page 354:
Page 358:
11. PCR and Its Variations 167 Prin
Page 362:
11. PCR and Its Variations 169 Exte
Page 366:
11. PCR and Its Variations 171 targ
Page 370:
11. PCR and Its Variations 173 bind
Page 374:
11. PCR and Its Variations 175 Reve
Page 378:
11. PCR and Its Variations 177 ampl
Page 382:
11. PCR and Its Variations 179 pres
Page 386:
11. PCR and Its Variations 181 Soft
Page 390:
11. PCR and Its Variations 183 Saik
Page 394:
12. Non-PCR Amplification 185 1989;
Page 398:
12. Non-PCR Amplification 187 FIGUR
Page 402:
12. Non-PCR Amplification 189 This
Page 406:
12. Non-PCR Amplification 191 FIGUR
Page 410:
12. Non-PCR Amplification 193 and c
Page 414:
12. Non-PCR Amplification 195 used
Page 418:
12. Non-PCR Amplification 197 do no
Page 422:
Application of the SDA Technique Re
Page 426:
12. Non-PCR Amplification 201 Ancho
Page 430:
12. Non-PCR Amplification 203 Baner
Page 434:
12. Non-PCR Amplification 205 Guilf
Page 438:
12. Non-PCR Amplification 207 Nilss
Page 442:
12. Non-PCR Amplification 209 Wang,
Page 446:
13. Recent Advances in Probe Amplif
Page 450:
Page 454:
Page 458:
Page 462:
Page 466:
Page 470:
Page 474:
Page 478:
Page 482:
14. Signal Amplification Techniques
Page 486:
Page 490:
TABLE 14.1. Comparison of bDNA and
Page 494:
Page 498:
Page 502:
References 14. Signal Amplification
Page 506:
Page 510:
15 Detection and Characterization o
Page 514:
15. Agarose Gel Electrophoresis, So
Page 518:
Page 522:
Page 526:
Page 530:
Page 534:
Page 538:
Page 542:
Page 546:
Page 550:
Page 554:
16. Direct Nucleotide Sequencing 26
Page 558:
Page 562:
Page 566:
Page 570:
Page 574:
Page 578:
17. Microarrays for Microbial Chara
Page 582:
Page 586:
Page 590:
Page 594:
Page 598:
Page 602:
Page 606:
18 Diagnostic Microbiology Using Re
Page 610:
TABLE 18.1. Comparison of four fluo
Page 614:
18. Real-Time PCR Based on FRET 295
Page 618:
Page 622:
Page 626:
Page 630:
Page 634:
Page 638:
19. Amplification Product Inactivat
Page 642: 19. Amplification Product Inactivat
Page 658: TABLE 19.1. Comparison of inactivat
Page 666: 20 Bacterial Identification Based o
Page 670: 20. Analysis of 16S rRNA Gene Seque
Page 686: 21 Molecular Techniques for Blood a
Page 690: Hepatitis B Surface Antigen (Anti-H
Page 696: TABLE 21.1. (Continued) Tradename(s
Page 700: 340 Y. Hu and I. Hirshfield gel ele
Page 704: 342 Y. Hu and I. Hirshfield Since 1
Page 708: 344 Y. Hu and I. Hirshfield they ar
Page 712: 346 Y. Hu and I. Hirshfield Antibod
Page 716: 348 Y. Hu and I. Hirshfield all ove
Page 720: 350 Y. Hu and I. Hirshfield chances
Page 724: 352 Y. Hu and I. Hirshfield Tang, Y
Page 728: 354 A. C. T. Lo and K. M. Kam in tu
Page 732: 356 A. C. T. Lo and K. M. Kam is no
Page 736: 358 A. C. T. Lo and K. M. Kam stabl
Page 740: 360 A. C. T. Lo and K. M. Kam Stran
Page 744:
362 A. C. T. Lo and K. M. Kam organ
Page 748:
364 A. C. T. Lo and K. M. Kam probe
Page 752:
366 A. C. T. Lo and K. M. Kam major
Page 756:
368 A. C. T. Lo and K. M. Kam Molec
Page 760:
370 A. C. T. Lo and K. M. Kam a sec
Page 764:
372 A. C. T. Lo and K. M. Kam cervi
Page 768:
374 A. C. T. Lo and K. M. Kam E6 an
Page 772:
376 A. C. T. Lo and K. M. Kam M. (2
Page 776:
378 A. C. T. Lo and K. M. Kam Hippe
Page 780:
380 A. C. T. Lo and K. M. Kam Larse
Page 784:
382 A. C. T. Lo and K. M. Kam Nobbe
Page 788:
384 A. C. T. Lo and K. M. Kam chlam
Page 792:
386 A. C. T. Lo and K. M. Kam ureal
Page 796:
388 A. Kilic and W. Drake Lipids wi
Page 800:
390 A. Kilic and W. Drake America,
Page 804:
392 A. Kilic and W. Drake MTB from
Page 808:
394 A. Kilic and W. Drake with anti
Page 812:
396 A. Kilic and W. Drake Molecular
Page 816:
398 A. Kilic and W. Drake and monit
Page 820:
400 A. Kilic and W. Drake system; t
Page 824:
402 A. Kilic and W. Drake transillu
Page 828:
404 A. Kilic and W. Drake Real-Time
Page 832:
406 A. Kilic and W. Drake Caws, M.,
Page 836:
408 A. Kilic and W. Drake Marttila,
Page 840:
410 A. Kilic and W. Drake Torres, M
Page 844:
412 P. Francois and J. Schrenzel an
Page 848:
414 P. Francois and J. Schrenzel th
Page 852:
416 P. Francois and J. Schrenzel A
Page 856:
418 P. Francois and J. Schrenzel St
Page 860:
420 P. Francois and J. Schrenzel Ac
Page 864:
422 P. Francois and J. Schrenzel or
Page 868:
424 P. Francois and J. Schrenzel Lo
Page 872:
426 P. Francois and J. Schrenzel Va
Page 876:
428 D. Ernst et al. several microme
Page 880:
430 D. Ernst et al. reanalysis to d
Page 884:
432 D. Ernst et al. Neisseria menin
Page 888:
434 D. Ernst et al. A. B. SEB-beads
Page 892:
436 D. Ernst et al. IL-6, IL-8, and
Page 896:
pg/ml 120 100 80 60 40 20 0 120 100
Page 900:
440 D. Ernst et al. Although interf
Page 904:
442 D. Ernst et al. Lal, G., Balmer
Page 908:
26 Molecular Strain Typing Using Re
Page 912:
446 S. R. Frye and M. Healy FIGURE
Page 916:
448 S. R. Frye and M. Healy Automat
Page 920:
450 S. R. Frye and M. Healy TABLE 2
Page 924:
452 S. R. Frye and M. Healy Noncomm
Page 928:
454 S. R. Frye and M. Healy 2001).
Page 932:
456 S. R. Frye and M. Healy (Stempe
Page 936:
458 S. R. Frye and M. Healy isolate
Page 940:
460 S. R. Frye and M. Healy molecul
Page 944:
462 S. R. Frye and M. Healy Boerlin
Page 948:
464 S. R. Frye and M. Healy Fey, P.
Page 952:
466 S. R. Frye and M. Healy Kwara,
Page 956:
468 S. R. Frye and M. Healy Pfaller
Page 960:
470 S. R. Frye and M. Healy Tang, Y
Page 964:
27 Molecular Differential Diagnoses
Page 968:
474 J. Han The technology advanceme
Page 972:
476 J. Han Targets Optimal Conditio
Page 976:
478 J. Han TABLE 27.1. Comparison o
Page 980:
480 J. Han TABLE 27.3. Comparison o
Page 984:
482 J. Han suspension hybridization
Page 988:
484 J. Han fluorescent dye is remov
Page 992:
486 J. Han TABLE 27.5. List of path
Page 996:
TABLE 27.8. Detection results of th
Page 1000:
490 J. Han common in HAI. In additi
Page 1004:
492 J. Han TABLE 27.12. Detection r
Page 1008:
494 J. Han TABLE 27.14. List of pat
Page 1012:
496 J. Han TABLE 27.18. Detectable
Page 1016:
TABLE 27.20. List of gene targets i
Page 1020:
500 J. Han Benefits and Impact: Del
Page 1024:
502 J. Han significantly increasing
Page 1028:
504 J. Han Hindiyeh, M., Hillyard D
Page 1032:
506 E. M. Marlowe and D. M. Wolk Al
Page 1036:
TABLE 28.1. Automated specimen proc
Page 1040:
510 E. M. Marlowe and D. M. Wolk Au
Page 1044:
512 E. M. Marlowe and D. M. Wolk La
Page 1048:
514 E. M. Marlowe and D. M. Wolk me
Page 1052:
516 E. M. Marlowe and D. M. Wolk mo
Page 1056:
518 E. M. Marlowe and D. M. Wolk Mo
Page 1060:
520 E. M. Marlowe and D. M. Wolk Ha
Page 1064:
522 E. M. Marlowe and D. M. Wolk Sa
Page 1068:
Index A acetate utilization, 100 Ac
Page 1072:
Index 527 rapid antigen tests, 27-2
Page 1076:
Index 529 flow cytometric immunoass
Page 1080:
Index 531 Human T-Lymphotropic Viru
Page 1084:
Index 533 MLEE. See multilocus enzy
Page 1088:
Index 535 PNA. See peptide-nucleic
Page 1092:
Index 537 Roseomonas, 328-329 rotav
Page 1096:
Index 539 T TaqMan probes, 293-296
show all

Advanced Techniques in Diagnostic Microbiology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?